SCHEMBL5653520

SCHEMBL5653520

CCOC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C(=O)OC

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.55
PYGL P06737 1/20 0.51
KLK5 Q9Y337 2/20 0.49
MMP8 P22894 1/20 0.48
LTA4H P09960 1/20 0.47
POLB P06746 1/20 0.47
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
RAB9A P51151 1/20 0.46
ALOX15 P16050 1/20 0.46
ATM Q13315 3/20 0.46
THRB P10828 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CTRB1 P17538 2/20 0.44
CTSL P07711 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6075360 1.00 TRPM8 (0.55) TRPM8PYGLKLK5MMP8LTA4H
SCHEMBL5652568 1.00 TRPM8 (0.55) TRPM8PYGLKLK5MMP8LTA4H
SCHEMBL5650046 0.90 TRPM8 (0.50) TRPM8PYGLKLK5MMP8ALDH1A1
SCHEMBL6091546 0.90 TRPM8 (0.50) TRPM8PYGLKLK5MMP8ALDH1A1
SCHEMBL5651683 0.90 TRPM8 (0.50) TRPM8PYGLKLK5MMP8ALDH1A1
SCHEMBL8163494 0.89 TRPM8 (0.69) TRPM8PYGLLTA4HALDH1A1ALOX15
SCHEMBL7418811 0.89 TRPM8 (0.69) TRPM8PYGLLTA4HALDH1A1ALOX15
SCHEMBL8623560 0.89 TRPM8 (0.69) TRPM8PYGLLTA4HALDH1A1ALOX15
SCHEMBL7415444 0.89 TRPM8 (0.69) TRPM8PYGLLTA4HALDH1A1ALOX15
SCHEMBL6945136 0.84 KLK5 (0.68) TRPM8PYGLKLK5ATMCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7307184-B2 Processes for preparing oxazolidinone derivatives of β-hydroxyethlamine compounds and for preparing β-hydroxyethlamine compounds KANEKA CORPORATION (JP) 2007-12-11 US disclosed
US-20060135784-A1 PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES KANEKA CORPORATION 2006-06-22 US disclosed
US-7057066-B2 Process for producing 3-amino-2-hydroxypropionic acid derivatives KANEKA CORPORATION (JP) 2006-06-06 US disclosed
US-20040181074-A1 Process for producing oxazolidinone derivative of beta-hydroxyethylamine compound and for producing beta-hydroxyethlamine compound KANEKA CORPORATION (JP) 2004-09-16 US disclosed
EP-1403257-A1 PROCESSES FOR PRODUCING OXAZOLIDINONE DERIVATIVE OF BETA-HYDROXYETHYLAMINE COMPOUND AND FOR PRODUCING BETA-HYDROXYETHYLAMINE COMPOUND KANEKA CORPORATION (JP) 2004-03-31 EP disclosed
EP-1300391-A1 PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES KANEKA CORPORATION (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135784-A1 PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES AASDHPPT, HPD, HAAO TRPM8 4687/4885PYGL 863/4885KLK5 2953/4885
US-20040181074-A1 Process for producing oxazolidinone derivative of beta-hydroxyethylamine compound and for producing beta-hydroxyethlamine compound HNMT, PNMT, HRH4 TRPM8 3960/4885PYGL 1002/4885KLK5 1847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.